LOW APTT AND BMI PREDICTS THE OCCURRENCE OF ISCHEMIC STROKE IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING DABIGATRAN

Dabigatran etexilate, oral direct inhibitors of thrombin, was demonstrated to be as efficacious and safe as warfarin in non-valvular atrial fibrillation (AF). However, it remains to be elucidated the usefulness of coagulation test to determine the proper dose of dabigatran to prevent cardiogenic